Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Advantest | 7.82% | $2.52M | $121.45B | 205.71% | 59 Neutral | |
| TSMC | 5.04% | $1.63M | $1.50T | 63.13% | 81 Outperform | |
| Novartis | 3.64% | $1.17M | $282.84B | 42.16% | 80 Outperform | |
| Roche Holding | 3.54% | $1.14M | $351.69B | 43.12% | 74 Outperform | |
| AstraZeneca | 2.84% | $917.56K | $288.07B | 29.97% | 79 Outperform | |
| Telefonaktiebolaget LM Ericsson | 2.81% | $907.63K | $36.57B | 41.06% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton SE | 2.76% | $892.15K | $321.43B | -12.58% | 75 Outperform | |
| Accenture | 2.67% | $860.24K | $166.40B | -31.39% | 79 Outperform | |
| L'Oreal | 2.56% | $826.46K | $241.31B | 22.08% | 71 Outperform | |
| H World Group | 2.44% | $788.44K | $15.15B | 46.63% | 74 Outperform |